Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease
Clinical trial NCT01661673 · COMPLETED
Trial details
- NCT number
- NCT01661673
- Sponsor
- FORUM Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-10-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.